Hemostatic analysis of a patient with hereditary angioedema undergoing coronary artery bypass grafting

Anesthesia and Analgesia

Volumn 93, Issue 6, 2001, Pages 1480-1482

  Chaney, James D ^a   Adair, Thomas M ^a   Lell, William A ^a   McGiffin, David C ^b   Nielsen, Vance G ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD CLOTTING DISORDER; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; DISEASE COURSE; FAMILY HISTORY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; HUMAN TISSUE; HYPERCOAGULABILITY; INFLAMMATION; PRIORITY JOURNAL; THROMBOELASTOGRAPHY;

EID: 0035193459     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200112000-00025     Document Type: Article

References (16)

1. Anaesthethic implications of hereditary angioneurotic oedema
2. Diseases of immediate type hypersensitivity
3. Hereditary angioneurotic oedema and blood-coagulation: Interaction between C1-esterase-inhibitor and the activation factors of the proteolytic enzyme systems
4. Clinical and biochemical effects of stanozolol therapy for hereditary angioedema
5. Hereditary angioedema: A decade of management with stanozolol
6. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: Comparison of treated and untreated patients
7. Complement activation during bypass in acquired C1 esterase inhibitor deficiency
8. Cardiopulmonary by-pass in a patient with acquired C1 inhibitor deficiency
9. Cardiopulmonary bypass in hereditary angioedema
10. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography
11. Evaluation of the contribution of platelets to clot strength in rabbits: Role of tissue factor and cytochalasin D
12. The use of citrated whole blood in thromboelastography
13. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay
14. Use of abciximab-modified thrombelastography in patients undergoing surgery
15. Assessing platelet and fibrinogen contribution to clot strength using modified thrombelastography in pregnant women
16. Double-blind randomized trial of perioperative fibrinolytic enhancement for femoropopliteal bypass